The Proteasome Activator PA200/PSME4: An Emerging New Player in Health and Disease

Proteasomes comprise a family of proteasomal complexes essential for maintaining protein homeostasis. Accordingly, proteasomes represent promising therapeutic targets in multiple human diseases. Several proteasome inhibitors are approved for treating hematological cancers. However, their side effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazgili, Ayse Seda, Ebstein, Frédéric, Meiners, Silke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406137/
https://www.ncbi.nlm.nih.gov/pubmed/36009043
http://dx.doi.org/10.3390/biom12081150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406137/
https://www.ncbi.nlm.nih.gov/pubmed/36009043
http://dx.doi.org/10.3390/biom12081150

Ejemplares similares